LUMO
Lumos Pharma, Inc. Common Stock
LUMO
LUMO
Delisted
LUMO was delisted on the 11th of December, 2024.
106 hedge funds and large institutions have $74.4M invested in Lumos Pharma, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 28 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
58% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 33
Holders
106
Holding in Top 10
–
Calls
$2.07M
Puts
$2.65M
Top Buyers
| 1 | +$1.5M | |
| 2 | +$1.23M | |
| 3 | +$1.07M | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$958K |
| 5 |
Axa
Paris,
France
|
+$797K |
Top Sellers
| 1 | -$7.55M | |
| 2 | -$4.72M | |
| 3 | -$3.19M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.09M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$2.11M |